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Abstract
Primitive neuroectodermal tumors (PNETs) are pedia-
tric brain tumors that result from defects in signaling
molecules governing the growth and differentiation of
neural progenitor cells. We used the RCAS–TVA system
to study the growth effects of three genetic alterations
implicated in human PNETs on a subset of neural
progenitor cells that express the intermediate filament
protein, nestin. The genetic alterations tested were: 1)
overexpression of the cellular oncoprotein, MYC;
2) activation of transcription factor, -catenin; and 3)
haploinsufficiency of Ptc, the hedgehog receptor gene.
The RCAS–TVA system uses an avian retroviral vector,
RCAS, to target gene expression to specific cell types in
transgenic mice. To express exogenous genes in neural
progenitor cells, we used Ntv-amice. In these mice, the
Nestin gene promoter drives expression of TVA, the cell
surface receptor for the virus. Ectopic expression of
MYC, but not activated -catenin, promoted the prolif-
eration of neural progenitor cells in culture and in the
cerebral leptomeninges in vivo. These effects were
equally penetrant in mice with Ptc + / and Ptc + / +
genetic backgrounds. Although overexpression of
MYC is not sufficient to cause intraparenchymal tumors,
it may facilitate PNET formation by sustaining the
growth of undifferentiated progenitor cells.
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Introduction
Primitive neuroectodermal tumors (PNETs) comprise a
class of malignant central nervous system (CNS) neo-
plasms that afflict young children. Most often, these tumors
arise in the cerebellum where they are called medulloblas-
tomas. The cells comprising medulloblastomas and other
PNETs closely resemble the neural progenitor cells found
normally in the CNS. That observation suggests that signal-
ing molecules governing the growth and differentiation of
CNS progenitor cells mediate PNET formation.
TheMyc family of proto-oncogenes plays a central role in
cell proliferation and differentiation (reviewed in Ref. [1 ] ) .
Overexpression of Myc may be a causative factor in PNET
formation. In support of this, amplification and overexpres-
sion of the human MYC gene occur in medulloblastoma cell
lines and primary tumors [2,3] . Furthermore, accumulation
of MYC mRNA in medulloblastomas is an unfavorable
prognostic indicator for patients [4 ] . In cultured cells, Myc
is expressed throughout the cell cycle, but the level of its
expression rises and falls in response to agents that stimulate
or repress mitosis. In situ hybridization studies in mouse
embryos show thatMycmRNA levels do not correlate directly
with proliferation in all tissues (reviewed in Ref. [5 ] ) . This
suggests that during embryonic development, Myc may
modulate cell activities in addition to proliferation. Down-
regulation of Myc generally correlates with terminal differ-
entiation. Myc immortalizes O-2A progenitor cells, but does
not block their differentiation into oligodendrocytes and
astrocytes [6] . The effect of Myc overexpression on CNS
progenitor cells in vivo is not known.
Another gene that may play a role in the pathogenesis of
PNETs is CTNNB1, which encodes the transcription factor,
 -catenin.  -catenin is a key downstream effector of the
WNT signal transduction pathway, which is crucial for CNS
development ( reviewed in Ref. [7 ] ) . In the cytoplasm,
 -catenin is held in a multiprotein complex, where it becomes
phosphorylated by glycogen synthase kinase (GSK) and
subsequently degraded via the ubiquitin–proteasome path-
way. WNT signaling blocks  -catenin degradation and
permits translocation of  -catenin to the nucleus, where it
activates transcription of target genes. Activating mutations in
the CTNNB1 gene have been reported in 4% of human
medulloblastomas [8] . These mutations encode N- terminal
amino acid substitutions that stabilize the protein by removing
phosphorylation sites critical for  -catenin degradation.
Although the frequency of  -catenin mutations in medullo-
blastomas is low, pathways leading to its activation may be
physiologically relevant to PNET biology.
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Another signaling pathway that contributes to PNET
formation is the Patched (Ptc ) signaling pathway. PTC is
the cell surface receptor for hedgehog, a class of secreted
proteins that play key roles in embryonic pattern formation
[9] . Inherited mutations in the human PTC gene segregate
in families with Gorlin’s Syndrome, a condition wherein
affected individuals develop neural tube defects, craniofa-
cial abnormalities, and predisposition to various neoplasms,
including medulloblastomas [10] . PTC gene mutations
have been reported in 3% to 14% of sporadic medullo-
blastomas [11–13] . Transgenic mice homozygous for
inactive Ptc alleles die during embryonic development with
open and overgrown neural tubes. Heterozygous (Ptc + /  )
mice develop features of Gorlin’s Syndrome, including
medulloblastomas [14,15] . Northern analysis showed that
full - length Ptc transcripts were present in these sponta-
neous tumors, indicating that haploinsufficiency, not a two-
hit mechanism of Ptc gene inactivation, is promoting
medulloblastoma growth [16,17] . We do not know if
mutations in MYC, CTNNB1, and PTC overlap in human
PNETs, or whether these mutations are found in separate
subgroups of tumors.
To study the effect of Myc dysregulation,  -catenin
activation, and Ptc haploinsufficiency on the growth of CNS
progenitor cells, we modeled these genetic alternations in
mice using the RCAS–TVA system [18,19] . This system
uses an avian leukosis virus vector (RCAS) to target gene
expression to specific cell types in transgenic mice. In these
mice, cell type–specific gene promoters drive expression of
TVA, the cell surface receptor for the virus. After infection,
RCAS sequences integrate randomly into the host cell
genome. There, the exogenous gene is expressed from a
spliced message under control of the constitutive retroviral
promoter, LTR. In mammalian cells, the retroviral genes are
spliced out so that virus replication cannot occur.
In this study, we used a line of transgenic mice (Ntv-a )
wherein the Nestin gene promoter drives expression of TVA
[20] . Nestin is an intermediate filament protein expressed by
CNS progenitor cells in vivo prior to their commitment to
either a neuronal or glial differentiation pathway [21] . Ntv-a
mice make it possible to express exogenous proteins in
nestin-expressing, CNS progenitors both in primary brain
cultures in vitro and inside the brain of live animals. Nestin-
expressing progenitors give rise to glioblastomas in vivo with
specific activation of the RAS and AKT signaling pathways
[22] and to oligodendrogliomas with overexpression of
platelet -derived growth factor [23] . It is possible that these
same progenitor cells can give rise to PNETs after
stimulation of the appropriate signaling pathways.
We show here that ectopic expression of MYC, but not
activated  -catenin, stimulates the proliferation of neural
progenitor cells in culture and in the cerebral leptome-
ninges in vivo. These mitogenic effects were equally
penetrant in mice with Ptc + /  and Ptc + / + genetic back-
grounds. Although overexpression of MYC is not sufficient
to cause intraparenchymal tumors, it may facilitate PNET




Production of the Ntv-a transgenic mouse line has been
described previously [20] . Ntv-a /Ptc + /  mice were cre-
ated by breeding Ntv-amice with mice containing a targeted
deletion of the Ptc gene [15] . Therefore, the mice used in
these experiments are mixtures of the following strains:
C57B6, BALB/C, FVB/N, and CD1.
In Vitro Growth Assays of CNS Progenitor Cells from Ntv-a
Mice
Primary brain cell cultures from newborn transgenic
mice were obtained by mechanical dissociation of the
whole brain, followed by digestion with trypsin (0.25% w/v)
for 15 minutes at 378C. Large debris was allowed to settle
and single cells were plated in Dulbecco’s modified Eagle’s
medium (DMEM; Gibco BRL, Grand Island, NY) supple-
mented with 10% (v/v) fetal bovine serum. To produce live
virus, we used DF-1 cells, an immortalized line of chicken
fibroblasts. DF-1 cells were cultivated in DMEM containing
5% fetal bovine serum, 5% calf serum, 1% chicken serum,
and 0.2% tryptose phosphate broth.
The supernatant from DF-1 cells, transfected with RCAS
vector and producing virus, was filtered (0.45 m) and
applied directly to subconfluent primary brain cultures from
Ntv-a mice. After exposure to three changes of viral
supernatant, brain cultures were harvested by trypsin
digestion and plated into tissue culture plates in growth
medium containing DMEM and 10% fetal bovine serum
(heat- inactivated at 568C for 30 minutes) .
To initiate a growth curve, 105 cells were plated in
triplicate and cultivated at 378C in an atmosphere of 5% CO2
and 95% air. At successive time points, the cells in each
plate were harvested and counted using a hemacytometer to
determine the total number of cells (average of three
plates) . After each time point, a fresh plate was seeded
with an aliquot of 105 cells. The percent change in cell
number between successive time points was used to
determine a running total cell number. For controls, we used
parallel cultures of cells infected with an RCAS vector
carrying the LACZ gene and cells that were not infected.
Anchorage- independent growth was determined using
the method of Hamburger and Salmon [24] . Cells (5103)
were suspended in culture medium (2 ml) containing 0.3%
agar (Difco Bactoagar, Detroit, MI) and plated over a layer
of 0.5% agar in the same culture medium. Triplicate cultures
were incubated at 378C under 5%CO2 and 95% air. Colonies
were counted 30 days after plating by viewing under a
microscope through a 20 objective and a graduated
eyepiece reticle. Any colonies larger than 38 m in diameter
( >10 cells ) were scored as positive. The efficiency of plating
was defined as the number of visible colonies as a
percentage of colonies plus single cells.
Direct In Vivo Infection of Transgenic Mice
DF-1 cells, transfected with RCAS vector and produc-
ing virus, were harvested by trypsin digestion, collected
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by centrifugation, washed, and resuspended in phos-
phate-buffered saline. A single injection of 1 to 2 l
containing 105 cells was made with a gas- tight Hamilton
syringe in the right frontal region of newborn mice, just
anterior to the coronal suture of the skull. The mice were
sacrificed 6 to 8 weeks after injection and their brains were
removed and fixed with formaldehyde (4% w/v) . Each brain
was divided into quarters by parallel incisions in the coronal
plane and embedded in paraffin. Tissue sections (4 m),
each containing all four brain quadrants, were mounted on
glass slides for histochemical and immunocytochemical
analysis.
Immunocytochemistry
To analyze protein expression in tissue sections, we
used an immunoperoxidase staining method described
previously [25] . Brain tissue sections, mounted on glass
slides, were deparaffinized with toluene, and then hydrated
through a descending series of ethanol. Sections were
immersed in an antigen-unmasking solution (Vector
Laboratories, Burlingame, CA) and exposed to two power
bursts in a microwave oven at full power (750 W) for
5 minutes each. Treatment with H2O2 (1% v/v) was carried
out for 10 minutes to quench endogenous peroxidase
activity. After immersion in normal goat serum (2%),
sections were incubated with primary antibody in a humid
chamber at 48C overnight. The avidin–biotin complex
technique was used to localize immunoreactivity ( IR) .
Sections were developed with diaminobenzidine (0.075%
w/v) –H2O2 (0.002% v/v) , then counterstained with tolui-
dine blue (0.1% w/v) . When using mouse monoclonal
antibodies, we followed the MOM kit protocol (Vector
Laboratories) to lower the background staining due to
endogenous mouse immunoglobulins.
RNA and Protein Expression Analysis
To detect human MYC and CTNNB1 mRNA in mouse
cells infected with RCAS vectors, we used total RNA
(100 ng) as template in one-step reverse transcription
polymerase chain reaction (RT-PCR) (Gibco BRL Super-
script ) with oligonucleotide primers specific for human MYC
and CTNNB1 coding sequences within the integrated RCAS
provirus. After 35 cycles of amplification, the PCR products
were resolved on 1.0% agarose gels, stained with ethidium
bromide, and visualized under ultraviolet light.
For analysis of protein expression, whole cell lysates of
culture cells were prepared by dounce homogenization in
lysis buffer containing 100 mM NaCl, 30 mM Tric–Cl (pH
7.6) , 1% (v/v) NP40, 30 mM NaF, 1 mM EDTA, 1 mM
sodium vanadate, 0.5 mM phenylmethylsulfonyl fluoride, and
a protease inhibitor cocktail (Boehringer Mannheim, Indian-
apolis, IN) . Lysates were incubated on ice for 45 minutes
and cellular debris was removed by centrifugation. Protein
samples (40 g) were resolved by SDS-PAGE using 10%
gels and transferred to nitrocellulose filters. Filters were
incubated in a blocking solution containing nonfat dry milk
(5% w/v) , 120 mM NaCl, 50 mM Tris–Cl (pH 7.4) , and
Tween-20 (0.1% v/v) . Primary antibody was applied to
filters in the blocking solution described above for 2 hours at
room temperature. Detection was carried out using perox-
idase-conjugated secondary antibody (goat antimouse
IgG) and enhanced chemiluminescence.
Antibodies
To detect protein expression by Western blotting and/or
immunocytochemistry, we used the following mouse mono-
clonal antibodies obtained from the indicated commercial
sources: 9E10 — MYC (Santa Cruz Biotechnology, Santa
Cruz, CA); 401 — nestin (Becton Dickinson PharMingen,
San Diego, CA) ; 35-Z6 — CD45 (Santa Cruz Biotechnol-
ogy) ; C19220 —  -catenin (Becton Dickinson Trans-
duction Laboratories, San Diego, CA) ; 2F11 — 70 kDa
Figure 1. Expression of RCAS–MYC and RCAS– - catenin in Ntv - a mouse
brain cultures. (A ) RCAS vector carrying exogenous gene (human c -MYC
cDNA) 3 0 of the retroviral env gene. Although RCAS vectors replicate only in
avian cells, the exogenous gene is expressed in both avian and mammalian
cells as a spliced message from the constitutive retroviral promoter, LTR. (B )
Western blot showing expression of humanMYC protein ( 67 kDa ) in a mouse
brain culture infected with RCAS–MYC retrovirus. No expression was
detected in cells infected with control virus carrying LACZ (9E10 antibody,
1:100 ) . (C ) RT -PCR analysis of brain cultures from three different Ntv -a
mice ( lanes 1–3 ) infected with RCAS–MYC or RCAS– - catenin and two
uninfected cultures ( lanes 4 and 5 ) . Total RNA was used as template in RT -
PCR reactions with oligonucleotide primers specific for either human MYC or
CTNNB1 coding sequences within the integrated RCAS proviruses. The MYC
product ( 838 bp ) or CTNNB1 (819 bp ) product was present in all infected
cultures, but in none of the uninfected cultures. As a positive control, we used
RNA from virus producer cell lines, DF1–MYC or DF1–CTNNB1 ( lane 6 ) .
Parallel PCRs showed no amplification from residual traces of genomic DNA
in the RNA samples ( lanes 1–6 ) .
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neurofilament protein (Dako, Carpinteria, CA); TuJ1 — III
tubulin (Sigma, St. Louis, MO); A6 — notch1 (Lab Vision,
Fremont, CA) . To detect GFAP expression, we used a
rabbit, anticow polyclonal antibody (Dako) .
Results
In Vitro Growth Stimulation of CNS Progenitor Cells by
RCAS–MYC
We prepared primary cultures of the whole brain from two
different strains of Ntv-a mice: one heterozygous for an
inactive Ptc gene (Ptc + /  ) and a second with wild- type
genetic background (Ptc + / + ) . Brain cultures were infected
in vitro with avian leukosis viruses (derived from RCAS
vectors) carrying the coding sequences of the genes, MYC
and CTNNB1. The RCAS–MYC vector contained full -
length, wild- type, human MYC cDNA (Figure 1A ) . The
RCAS– -catenin vector contained a mutant  -catenin
allele encoding an S37A amino acid substitution. This
mutation renders  -catenin refractory to phosphorylation
by GSK and hence resistant to degradation [26] . Mutations
in the human CTNNB1 gene encoding serine 37 substitu-
tions occur in sporadic medulloblastomas [8] . We demon-
strated MYC and  -catenin expression in infected cultures
by Western blotting and by RT-PCR analysis using
oligonucleotide primers specific for the human MYC and
CTNNB1 sequences in the respective RCAS vectors (Figure
1B and C ) .
To quantify the population of nestin-expressing cells
susceptible to infection by RCAS vectors, we prepared
separate, primary brain cultures from six mice at P0. Three
Figure 2. In vitro growth stimulation of Ntv - a mouse brain cultures by RCAS–MYC. (A–C) Cell growth curves for Ntv - a mouse brain cultures infected with the
indicated RCAS vectors. Cultures were derived from the following mice: (A ) R4 with Ptc + /  genetic background, (B ) WT3 with Ptc + / + background, and (C ) R7
(Ptc + /  ) and WT6 (Ptc + / + ) . Data points represent averages of three cell counts with standard deviations less the 38% of the mean (highly significant on the log
scale ) . (D–E ) Phase contrast photomicrographs showing cell morphology of Ntv -a brain culture R2 (Ptc + /  ) infected with RCAS–MYC (D ) and uninfected
(E ) . Cells were photographed after comparable time periods in culture. Scale bar, 70 m.
Table 1. Colony -Forming Efficiency (%) * in Soft Agar of Ntv -a Brain
Cultures Infected with RCAS Vectors.
RCAS Vector Genetic Background
Ptc + / + Ptc + / 
MYC 1.7 8.0




*Colony - forming efficiency= { [ number of colonies ( number of colonies+
single cells ) ]100}.
yMTA — polyomavirus middle T antigen.
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days later, we carried out immunoperoxidase staining with
antibodies for nestin and GFAP. The percentage of nestin+
cells averaged 44% (range=28% to 54%) and the
percentage of GFAP+ cells averaged 57% (range=41% to
59%). To determine the efficiency of RCAS infection, we
infected three brain cultures with RCAS–LACZ and per-
formed a colorimetric assay for the expressed gene product
3 days later. The percentage of LACZ+ cells averaged 47%
2(range 32% to 60%). These results indicated that primary
brain cultures from newbornNtv-amice contain an abundant
pool of nestin-expressing cells that can be infected with
RCAS vectors with high efficiency.
We studied the growth properties of infected cultures in
two ways: 1) plotting cell growth curves and 2) measuring
colony- forming efficiency in soft agar media. Cultures
infected with RCAS–MYC showed a growth advantage
compared to those infected with RCAS– -catenin or
uninfected controls. This effect was observed in six
independent brain cultures ( three from Ntv-a /Ptc + /  mice
and three from Ntv-a /Ptc + / + mice) . Figure 2A and B show
the results with two cells lines, R4 and WT3.
After 23 days in culture, cells infected with RCAS– -
catenin and uninfected controls had a similar growth rate of
one population doubling per 24 hours. By contrast, infection
with RCAS–MYC stimulated this rate three- fold and six- fold
in Ptc + /  and Ptc + / + cells, respectively. Although we
observed variation in basal growth rates of uninfected cells
from different mice, RCAS–MYC infection significantly
enhanced the growth rate in every case. Comparison of
the growth curves from Ptc + /  and Ptc + / + brain cultures
(mock- infected with RCAS–LACZ) showed that Ptc + / 
cells had a slightly higher growth rate initially (Figure 2C ) .
After 15 days in culture, however, the growth rates of Ptc + / 
and Ptc + / + cultures had become identical. A positive control
virus carrying the polyomamiddle T oncogene stimulated cell
growth in every case (data not shown).
Consequent to infection with RCAS–MYC a distinct,
morphologic change occurred in the brain cell cultures. Flat,
polygonal cells in early passage cultures acquired a
refractile, spindle-shaped appearance and a marked ten-
dency to form multicellular aggregates (Figure 2D ) .
Compared to  -catenin–expressing cells or uninfected
controls (Figure 2E ) , MYC-expressing cells lost contact
inhibition and grew to very high cell density in culture.
In soft agar, we observed a low level of anchorage-
independent growth following infection with RCAS–MYC
(1.7% and 8.0% colony- forming efficiencies in Ptc + / + and
Ptc + /  cells, respectively ) (Table 1) . This effect was far
weaker than that of RCAS–MTA, carrying the potent
transforming oncogene, polyoma middle T. The observed
increase in colony- forming efficiency of cells infected with
RCAS–MYC compared to uninfected control cells was not
statistically different (P=.245 and .407 by t - test in Ptc + / +
and Ptc + /  cells, respectively ) . A trend toward anchorage-
independent growth after infection with RCAS–MYC was
observed inPtc + /  cells compared toPtc + / + cells (P=.120
by t - test ) .
Immunocytochemical analysis of late-passage brain
cultures (at the end of the growth curve experiments)
showed that nearly 100% of cells was nestin+ and only
occasional clusters of cells were GFAP+ (Figure 3E ) . This
staining pattern was observed in cultures infected with
RCAS–MYC, RCAS– -catenin, and in uninfected cultures.
These results indicate that the culture conditions ( including
serum-containing media) do not induce terminal differ-
entiation, but rather sustain an undifferentiated phenotype of
neural progenitor cells. Furthermore, genotyping by PCR of
late-passage brain cultures infected with RCAS–MYC,
RCAS– -catenin, and in uninfected controls showed that
both wild - type and recombinant Ptc alleles were present.
We concluded from these in vitro studies that ectopic
expression of MYC selects for cells with marked proliferative
capacity and morphologic changes in culture. Furthermore,
heterozygous loss of Ptc cooperates with MYC overexpres-
sion to promote anchorage- independent growth of CNS
progenitor cells in culture.
Direct In Vivo Gene Transfer of RCAS–MYC in Ntv-a
Transgenic Mice
To determine the effect of transferring RCAS–MYC into
nestin-expressing progenitor cells in vivo, we injected ALV
producer cells directly into the brains of 53 newborn Ntv-a
mice. These test animals comprised six litters arising from
matings between Ntv-a /Ptc + /  parents. Six to 8 weeks
later, the mice were sacrificed and their brains were removed
for histologic and immunocytochemical analysis. Five mice
were sacrificed 3 to 4 weeks after injection because they
showed signs of increased intracranial pressure. The brains
from 51 animals were available for analysis. After genotyping
for Ptc, we divided the mice into two groups, Ptc + /  (n=36)
and Ptc + / + (n=15) . These proportions reflect the expected
distribution of alleles arising from matings between hetero-
zygous parents (Ptc nullizygotes die early in embryonic
development) .
We found aggregates of cells with hyperchromatic nuclei
within the leptomeninges of the brain in 27/36 (75%) Ptc + / 
Figure 3. Histopathology of leptomeningeal cell aggregates induced by RCAS–MYC. (A ) Cell aggregate abutting pial surface of the brain from Ntv - a /Ptc + / 
mouse (M35 ) injected with RCAS–MYC. An artery within the subarachnoid space is visible in the upper left. H&E. (B ) Immunoperoxidase staining of Ntv -a /
Ptc + /  mouse brain section (M129 ) using antibody, 9E10 (1:50 ) , specific for human MYC. Cells within the subarachnoid space show nuclear IR (arrows )
and cytoplasmic IR (arrowhead ) . (C ) Immunoperoxidase staining of Ntv -a /Ptc + / + mouse brain section (M108 ) showing MYC IR (9E10 antibody, 1:50 ) .
All cells in the aggregate show cytoplasmic staining. (D ) Immunoperoxidase staining of the same mouse brain specimen as shown in panel C (M111 ) , using
antibody, 35 -Z6 (1:50 ) , specific for leukocyte transmembrane protein, CD45. Only a few scattered cells are CD45+ ( arrows ) . (E ) Nestin expression in Ntv - a
brain culture infected with RCAS–MYC (401 antibody, 1:500 ) . ( F ) Leptomeningeal cell aggregate in Ntv -a /Ptc + /  mouse brain (M111 ) showing
expression of nestin (401 antibody, 1:50 ) . (G ) Leptomeningeal cell aggregate in Ntv -a /Ptc + /  mouse brain (M129 ) showing expression of notch1 (A6
antibody, 1:50 ) . (H ) Leptomeningeal cell aggregate in Ntv - a /Ptc + / + mouse brain (M108 ) showing expression of III tubulin (TuJ1 antibody, 1:400 ) . Scale
bar, 15 m for panels A–E; 9 m for panels F–H.
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specimens and in 11/15 (73%) Ptc + / + specimens
(Figure 3A ) . In no case did we see a solid tumor mass
within the brain parenchyma. Microscopic examination of
brains from 18 mice injected with RCAS– -catenin
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showed neither tumors nor leptomeningeal cell aggregates
in any mouse.
To determine whether these cell aggregates arising in
mice infected with RCAS–MYC were the result of virally
expressed human MYC, we carried out immunoperoxidase
staining of brain sections using monoclonal antibody, 9E10.
This antibody recognizes human MYC, but not endogenous
mouse MYC, in formalin - fixed, paraffin -embedded tissue
sections. Cells within the leptomeningeal aggregates
showed 9E10 IR, indicating expression of MYC from the
integrated RCAS provirus. In these cells, we observed both
nuclear and cytoplasmic IR (Figure 3B and C ) . To exclude
the possibility that these cells might be inflammatory
leukocytes, we stained adjacent sections with monoclonal
antibody, 35-Z6, specific for CD45, a transmembrane
protein widely expressed in hematopoietic cells. Only a few
scattered cells were CD45+ (Figure 3D ) .
To characterize these leptomeningeal aggregates further,
we stained brain sections with antibodies for nestin, III
tubulin, and notch1 — markers for neural progenitor cells.
Approximately 10% to 20% of cells within the leptomeningeal
aggregates was nestin+ (Figure 3F ) . The cell type
specificity of the RCAS–TVA system is limited to the original
gene transfer event. Afterwards, the transferred gene is
expressed from the viral LTR. Therefore, there is no
selective pressure for infected cells to maintain nestin
expression in vivo.
In contrast to the variable expression of nestin, 100% of
the cells expressed notch1 (Figure 3G ) . Notch1 is a cell
surface receptor whose activation in CNS progenitors
inhibits neuronal and oligodendroglial differentiation
[27,28] . In addition, approximately 10% of the leptomenin-
geal aggregates contained III tubulin+ cells (Figure 3H ) .
Expression of III tubulin by CNS progenitor cells is an early
marker of neuronal differentiation [29] . We did not detect
expression of GFAP or neurofilament protein, markers for
terminally differentiated astrocytes and neurons. Taken
together, these immunocytochemistry results indicate that
the MYC-expressing, leptomeningeal cells are undifferenti-
ated CNS progenitors. Expression of III tubulin suggests a
capacity to differentiate along a neuronal pathway. Further-
more, the Ptc genetic background does not appear to alter
this effect.
Discussion
We show here that ectopic expression of MYC stimulates the
growth of CNS progenitor cells and leads to their accumu-
lation in the cerebral leptomeninges. The leptomeningeal
pattern of cell growth induced by overexpressedMYC inmice
mimics the tendency of human medulloblastomas to invade
the subarachnoid spaces of the brain. In fact, subarachnoid
tumor spread correlates with shortened survival in patients
( reviewed in Ref. [30] ) . Also, increased expression ofMYC
is an unfavorable prognostic factor for medulloblastoma
patients [4 ] . These clinical correlations suggest that MYC or
signaling pathways that upregulate MYC may mediate this
leptomeningeal pattern of tumor growth.
In vivo, RCAS–MYC promoted growth of progenitor cells
only in the leptomeninges. One possible explanation for this
phenomenon is that physical contact with leptomeningeal
cells may be required for sustained growth of CNS progenitor
cells. In support of this, cultivation of human medulloblas-
toma cells on a monolayer of leptomeningeal cells prolongs
cell viability compared to growth on plastic surfaces [31] .
Numerous cell signaling pathways converge upon
 -catenin ( reviewed in Ref. [32] ) . The occurrence of
mutations that activate  -catenin in human medulloblasto-
mas implicates one or more of these pathways in PNET
formation. We did not find a proliferative effect of  -catenin
in our mouse model system. Kolligs et al., using retroviral
expression, showed that activated  -catenin, lacking GSK
phosphorylation sites, failed to transform mouse NIH3T3
fibroblasts, rat IEC-18 intestinal epithelial cells, or human
1811 squamous epithelial cells. However, these  -catenin
mutants were able to transform a rat kidney cell line (RK3E)
that had been immortalized by adenovirus E1A [33] . These
experiments imply that  -catenin is capable of cooperating
with molecules, like E1A, that disrupt cell cycle arrest. In
addition, expression of activated  -catenin in Ntv-a mice
may have a weak genetic effect detectable only after a longer
period of observation. For these reasons, we cannot
conclude from our experiments that  -catenin is not involved
in the pathogenesis of PNETs. If  -catenin does contribute
to PNET formation, it most likely does so through collabo-
ration with other signaling molecules.
Further evidence that multiple signaling pathways coop-
erate in PNET formation is the fact that medulloblastomas
arise spontaneously in only 14% to 30% of Ptc + /  mice
[14,16] . The incomplete penetrance of Ptc on tumor
formation in mice, coupled with the low frequency of PTC
mutations in human tumors, suggests that additional
molecules are involved. One of these is insulin- like growth
factor 2. Tumor formation is completely eliminated in mice
that are Igf2  /  /Ptc + /  double mutants [34] . Loss of p53
accelerates medulloblastoma formation in Ptc + /  mice,
possibly by increasing genomic instability [35] . However,
P53 gene mutations are rarely found in medulloblastomas.
Dysregulation of MYC may be another factor promoting
PNET formation by sustaining the growth of undifferentiated,
CNS progenitor cells or by facilitating leptomeningeal spread
of tumor cells. Our experimental observation, that MYC
promotes colony formation in soft agar more efficiently in
Ptc + /  cells, suggests that MYC overexpression and Ptc
haploinsufficiency may cooperate to enhance tumor cell
growth in human PNETs.
In these studies, we have investigated the in vivo effects
of several genetic changes found in human PNETs but we
have not generated tumors. The cell -of -origin for cerebral
PNETs remains unknown. Strong evidence points to a
neuronal precursor in the external granular layer of the
cerebellum as the cell -of -origin for medulloblastomas [36] .
It is possible that in vivo gene transfer ofMYC or CTNNB1 to
a cell type other than nestin-expressing CNS progenitors
might give results different from those reported here for the
Ntv-a mouse line. Furthermore, our gene transfer experi-
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ments were carried out in postnatal mice. It is possible that
the nestin+ cells present in the cerebrum at that devel-
opmental time point may not give rise to PNETs. We do know
that these cells are capable of transformation into gliomas
with appropriate genetic alterations [22,23] .
The study reported here demonstrates the utility of the
RCAS–TVA system for testing the individual contributions of
oncogenes and tumor-suppressor genes to CNS progenitor
cell growth. Although MYC dysregulation recapitulates the
leptomeningeal pattern of PNET growth, further research will
be needed to identify the molecular defects required to
transform progenitor cells completely and cause PNETs to
form inside the brain parenchyma.
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